823200_DG2_CAR-TCR Summit_Final_1080x360 (1).jpg

CELL AND GENE THERAPY

9th Annual CAR-TCR Summit

Sept. 17-20

Hynes Convention Center
900 Boylston St., Boston, MA 02115

 

Schedule a meeting

Being a trusted leader in the cell therapy landscape, Labcorp is at the forefront of advancing cell therapy and CAR-TCR innovations. Our state-of-the art facilities and expert scientific teams provide robust support for biomarker discovery, immune-oncology and personalized medicine. Leveraging flow cytometry, we deliver high throughput and quantitative analysis of the immune system to provide actionable insights into therapeutic efficacy and patient outcomes. With a commitment to scientific excellence, we continue empowering our collaborators to bring groundbreaking cell therapies to market efficiently and effectively. 

During this year's summit, be sure to join us for a special presentation on cutting-edge strategies shaping the next generation of cell therapy techniques.

With global laboratory resources focused on advanced therapies, our team is here to help propel your cell or gene therapy (CGT) program by bringing scientific insights across every stage of development.
 

Schedule a meeting

PRESENTATION

Flowing Forward: Flow Cytometry Strategies for Tomorrow’s Adoptive Cell Therapies

Thursday, Sept. 19 | 11:55 a.m.

Leanne Flye-Blakemore

Associate Director of Scientific Operations for Flow Cytometry, Labcorp

  • More than 24 years of experience in clinical assay development, spanning therapeutic types including small molecules, antibodies and CGTs across a wide array of disease indications including oncology, infectious disease and autoimmunity
  • Leads a global team in developing and validating innovative assays to support novel therapeutic efficacy assessments
  • Holds three patents in novel flow assays to assess signaling cascade events that can be predictive of therapeutic response and/or prognosis


In this presentation, Leanne will discuss:

  • Critical cellular biomarkers of persistence and clinical efficacy
  • Accelerated immune monitoring strategies with backbone panel development for faster implementation
  • Sample type considerations, now and tomorrow
  • Standardization for global deployment—ensuring consistency in data for long-term follow-up studies

POSTER PRESENTATION

A novel 30-color spectral flow cytometry panel for T cell therapy phenotypic characterization

Tuesday, Sept. 17 | 6 p.m.

David Draper

Associate Director of Scientific Development for Preclinical Oncology, Labcorp

  • More than 25 years of flow cytometry and general in vitro service experience in life science research, clinical hematology, and drug discovery
  • Leads a team that supports proposal design for oncology/immunology studies to ensure the best analytical service is utilized for the needs of the drug developer
  • Oversees research and development into new service innovation in the preclinical oncology space

CELL THERAPY WORKSHOP

Let’s connect on ways to address common challenges in navigating cell therapy development!

Join us for an exclusive, in-person cell therapy workshop - Optimizing Cell Therapy Discovery for Clinical Transition. During this complimentary workshop, we will explore key challenges in cell therapy development, and discuss how well-designed and executed discovery services can streamline the transition to clinical trials, minimize risk and optimize your time and resources.

Date: September 16, 2024 | Time: 3:00 – 6:00 PM EST | Venue: Hilton Boston Back Bay

Register today
Visit our website to learn more